rs386134197
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP5
The NM_003060.4(SLC22A5):āc.557T>Cā(p.Leu186Pro) variant causes a missense change. The variant allele was found at a frequency of 0.00000657 in 152,276 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003060.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152276Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251492Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135918
GnomAD4 exome Cov.: 31
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152276Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74398
ClinVar
Submissions by phenotype
Renal carnitine transport defect Pathogenic:3Uncertain:2
Variant summary: SLC22A5 c.557T>C (p.Leu186Pro) results in a non-conservative amino acid change located in the Major facilitator superfamily domain (IPR020846) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251492 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.557T>C has been reported in the literature in at least one compound heterozygous individual affected with Systemic Primary Carnitine Deficiency (e.g., Frigeni_2017). At least two publications report experimental evidence evaluating an impact on protein function, finding that the variant results in <2% of normal carnitine transport activity (e.g., Frigeni_2017, Koleske_2022). The following publications have been ascertained in the context of this evaluation (PMID: 32778825, 28841266, 36343260, 20574985). Three ClinVar submitters (evaluation after 2014) have cited the variant with conflicting assessmements: 1 submitter classified the variant as pathogenic, and 2 submitters classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
- -
- -
- -
This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 186 of the SLC22A5 protein (p.Leu186Pro). This variant is present in population databases (rs386134197, gnomAD 0.007%). This missense change has been observed in individual(s) with primary carnitine deficiency (PMID: 20574985, 28841266; internal data). ClinVar contains an entry for this variant (Variation ID: 38287). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt SLC22A5 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects SLC22A5 function (PMID: 28841266). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at